E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/7/2016 in the Prospect News Convertibles Daily.

New Issue: Insulet prices upsized $300 million 1.25% five-year convertibles, up 32.5%

By Angela McDaniels

Tacoma, Wash., Sept. 7 – Insulet Corp. priced an upsized $300 million of 1.25% five-year convertible senior notes at par on Wednesday with an initial conversion premium of 32.5%, according to a company news release.

The Rule 144A deal was initially talked at $250 million. Pricing came at the rich end of talk that was for a 1.25% to 1.75% coupon and a 27.5% to 32.5% premium.

The greenshoe was upsized to $45 million from $37.5 million.

The joint bookrunners were Morgan Stanley & Co. LLC and Wells Fargo Securities LLC.

The notes are non-callable for three years and then provisionally callable if shares exceed 130% of the conversion price. There are no puts.

The securities have contingent conversion with a 130% share price threshold and net share settlement.

There is dividend protection for any dividends paid and takeover protection via a standard make-whole matrix.

The company plans to use about $154 million of the proceeds to repurchase about $134 million of its 2% convertible senior notes due 2019. The remaining proceeds will be used for general corporate purposes, which may include buying back more of Insulet’s remaining 2% convertibles, as well as investment in its manufacturing and supply chain operations.

Insulet is a Bedford, Mass.-based medical device maker.

Rebecca Melvin contributed to this story

Issuer:Insulet Corp.
Issue:Convertible senior notes
Amount:$300 million, upsized from $250 million
Greenshoe:$45 million, upsized from $37.5 million
Maturity:Sept. 15, 2021
Bookrunners:Morgan Stanley & Co. LLC, Wells Fargo Securities LLC
Coupon:1.25%
Price:Par
Yield:1.25%
Conversion premium:32.5%
Conversion price:$58.37
Conversion ratio: 17.1332 shares
Calls:Non-callable for three years, then provisionally callable at 130% price hurdle
Puts:No puts
Contingent conversion:Yes
Net share settlement:Yes
Dividend protection:Yes
Takeover protection:Yes, standard make-whole
Price talk:1.25%-1.75%, up 27.5%-32.5%
Pricing date:Sept. 7
Settlement date:Sept. 13
Distribution:Rule 144A
Stock symbol:Nasdaq: PODD
Stock reference price:$44.05 as of close Sept. 7
Market capitalization:$2.52 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.